Filing Details
- Accession Number:
- 0001209191-15-061930
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-07-21 18:41:44
- Reporting Period:
- 2015-07-17
- Filing Date:
- 2015-07-21
- Accepted Time:
- 2015-07-21 18:41:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1439222 | Agios Pharmaceuticals Inc | AGIO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1581992 | Glenn Goddard | C/O Agios Pharmaceuticals, Inc. 88 Sidney Street Cambridge MA 02139 | Senior Vice President, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-07-17 | 909 | $0.69 | 909 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-07-17 | 7,273 | $2.34 | 8,182 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-07-17 | 3,725 | $9.05 | 11,907 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-07-17 | 1,093 | $23.10 | 13,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-07-17 | 13,000 | $113.71 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option (right to buy) | Disposition | 2015-07-17 | 909 | $0.00 | 909 | $0.69 |
| Common Stock | Stock option (right to buy) | Disposition | 2015-07-17 | 7,273 | $0.00 | 7,273 | $2.34 |
| Common Stock | Stock option (right to buy) | Disposition | 2015-07-17 | 3,725 | $0.00 | 3,725 | $9.05 |
| Common Stock | Stock option (right to buy) | Disposition | 2015-07-17 | 1,093 | $0.00 | 1,093 | $23.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 108,189 | 2021-09-14 | No | 4 | M | Direct | |
| 100,916 | 2022-04-05 | No | 4 | M | Direct | |
| 97,191 | 2023-04-29 | No | 4 | M | Direct | |
| 96,098 | 2023-08-27 | No | 4 | M | Direct |
Footnotes
- This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $113.19 to $114.85. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price
- This option was granted on September 15, 2011. The shares underlying this option vest as to 25% of the underlying shares on September 15, 2012, with the remaining 75% vesting in 36 equal monthly installments thereafter.
- This option was granted on April 6, 2012 for the purchase of 29,090 shares of common stock. The option vests as to 25% of the underlying shares upon the achievement of a performance milestone, as to an additional 50% upon the achievement of a second performance milestone, and as to the remaining 25% on the first anniversary of the first date that both performance milestones were achieved. The performance criteria for the first performance milestone were met on March 18, 2013. The performance criteria for the second performance milestone were met on April 4, 2014, resulting in the vesting of the option as to 14,545 shares, and the remaining 7,273 shares will vest on April 4, 2015.
- This option was granted on April 30, 2013 for the purchase of 14,545 shares of common stock. The option vests as to 25% upon the achievement of a performance milestone, as to an additional 50% of the underlying shares upon the achievement of a second performance milestone, and as to the remaining 25% on the first anniversary of the first date that both performance milestones were achieved. The performance criteria for the first performance milestone was met on January 17, 2014. The performance criteria for the second performance milestone was met on April 4, 2014, resulting in the vesting of the option as to 7,273 shares, and the remaining 3,636 shares will vest on April 4, 2015.
- This option was granted on August 28, 2013. The shares underlying this option vest as to 25% of the underlying shares on August 28, 2014, with the remaining 75% vesting in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
